Shire BioChem inc.

Shire BioChem inc.

Saint-Laurent, QC

Company Overview

Shire Pharmaceuticals Group plc (Shire) is a global pharmaceutical company with a strategic focus on meeting the needs of the specialist physician and currently focuses on developing projects and marketing products in the areas of central nervous system (CNS), gastrointestinal (GI), and renal diseases. Shire has operations in the worlds key pharmaceutical markets (US, Canada, UK, France, Italy, Spain and Germany) as well as a specialist drug delivery unit in the US.

Company Information

Physical Address

2250, BOUL. ALFRED-NOBEL, BUREAU 500
Saint-Laurent, QC H4S 2C9
CA

Mailing Address

2250, BOUL. ALFRED-NOBEL, BUREAU 500
Saint-Laurent, QC H4S 2C9
CA

Phone

Phone: Show phone

Toll Free: Show toll free

Fax: Show fax

Online

Email: Show email

Website: http://www.shire.com

Additional Details

Legal Name: Shire BioChem inc.

Number of Employees: 75

Contacts

Michel Florio

Title: Directeur des Ventes

Phone: Show phone

Fax: Show fax

Email: Show email

Products

  • 3tc, Epivir, Combivir, Trizivir
  • Agrylin

    Agrylin has been introduced in Canada in 1998 for the treatment of essential thrombocythaemia, a chronic disorder associated with increased or abnormal production of blood platelets.

  • Alertec

    Wake promoting agent in narcolepsy

  • Hectorol

    Vitamin D analog for the treatment of secondary hyperparathyroidism in patients undergoing dialysis.

  • Heptovir

    Lamivudine has also been shown to be effective in treating patients with chronic Hepatatis B infection and is available as HEPTOVIR for this indication. In an agreement similar to that for lamivudine in HIV/AIDS, Shire receives royalties on sales, except in Canada where we have a business partnership with GSK.

  • Permax

    PERMAX (pergolide mesylate), a synthetic ergot derivative, is a dopamine receptor agonist at both D1 and D2 receptor sites. PERMAX (pergolide mesylate) is indicated in the treatment of the signs and symptoms of idiopathic Parkinsons disease. PERMAX (pergolide mesylate) may be used both as early therapy, without concomitant levodopa, and as an adjunct to levodopa (usually with a peripheral decarboxylase inhibitor).

  • Zanaflex

    ZANAFLEX (tizanidine hydrochloride) is an agonist at 2-adrenergic receptor sites and presumably reduces spasticity by increasing presynaptic inhibition of motor neurons. ZANAFLEX (tizanidine hydrochloride) is a short-acting drug for the management of spasticity.

NAICS Categories

Additional Information

NAICS:

325410

Export Experience:

Argentina